Citizen Petition from Pharmaceutical Safety Oversight Council

The commenter is a pet owner who shares a personal story about their dog's severe adverse reactions to the drug Librela. They are urging the agency to remove the product from the market or issue a warning to veterinarians and owners.

An individual is sharing a personal anecdote about their dog suffering a severe adverse reaction (seizures) after receiving a Librela injection. By providing this testimony in response to a petition regarding pharmaceutical safety oversight, the commenter supports the action of increased oversight.

An individual pet owner shares a personal account of their dog's death following the administration of Librela, citing severe adverse reactions. The commenter supports the petition by highlighting the dangers of the medication and the lack of transparency regarding side effects.

A pet owner is requesting the recall of the anti-NGF monoclonal antibody injection Librela after their dog died following its administration. The commenter argues that the drug is dangerous and deadly, citing severe adverse reactions and necropsy results as evidence.

A veterinarian (implied by the description of managing patients and advising owners) provides anecdotal evidence of severe joint destruction and neurological side effects in patients treated with Librela. The commenter supports the petition by providing specific clinical cases of adverse reactions to the medication.

The commenter is a pet owner who argues that the drug Librela is dangerous and should be pulled from the market. They support the citizen petition by requesting additional safety studies, stronger warning labels, and independent reviews of the drug's safety data.